Accure Therapeutics of Barcelona, Spain has been launched by investors in order to develop new therapies for diseases of the central nervous system (CNS). A Series A financing round amounting to €7.6 million was announced on 26 May, led by Alta Life Sciences and supported by the Centre for Technological and Industrial Development, an organ of the Spanish state.
